High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT Peripheral blood stem cell transplants have been associated with better response rates than conventional chemotherapy in patients with primary systemic amyloidosis. A higher
incidence of gastrointestinal (GI) tract bleeding has been observed among amyloidosis patients undergoing peripheral stem cell transplantation. We retrospectively reviewed the medical
records of such patients to identify those who had GI tract bleeding in the post-transplant period. Forty-five patients were studied. Nine patients had GI tract bleeding in the
post-transplant period. The median post-transplant duration to onset of bleeding was 9.5 days (range 1 to 48 days). Three patients had lower GI tract bleeding, two had upper GI tract
bleeding, and four had both. Diffuse esophagitis and gastritis were the most common findings on endoscopy. There were no correlations among the age, platelet nadir, or CD34 count of the
graft and the risk of bleeding. Women were more likely to have GI tract bleeding (_P_ = 0.015), as were patients with slow platelet engraftment (_P_ = 0.02). Patients with multiorgan
involvement and those on hemodialysis appeared to be at a higher risk of GI tract bleeding. The mean post-transplant hospital stay for those with GI tract bleeding was 37 days compared with
14.5 days for those who did not have GI tract bleeding (_P_ = 0.0047). _Bone Marrow Transplantation_ (2001) 28, 381–385. Access through your institution Buy or subscribe This is a preview of
subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only
$21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout
ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS IDENTIFICATION OF ENDOSCOPIC
FACTORS THAT PREDICT POOR RESPONSES TO STEROIDS IN PATIENTS WITH GASTROINTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE Article 02 November 2020 OVERT GASTROINTESTINAL BLEEDING FOLLOWING
HAPLOIDENTICAL HAEMATOPOIETIC STEM CELL TRANSPLANTATION: INCIDENCE, OUTCOMES AND PREDICTIVE MODELS Article 07 January 2021 OUTCOMES OF RENAL TRANSPLANTATION IN PATIENTS WITH AL AMYLOIDOSIS:
AN INTERNATIONAL COLLABORATION THROUGH THE INTERNATIONAL KIDNEY AND MONOCLONAL GAMMOPATHY RESEARCH GROUP Article Open access 18 August 2022 REFERENCES * Kyle RA, Gertz MA . Primary systemic
amyloidosis: clinical and laboratory features in 474 cases _Semin Hematol_ 1995 32: 45–59 CAS PubMed Google Scholar * Skinner M, Anderson J, Simms R _et al_. Treatment of 100 patients
with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only _Am J Med_ 1996 100: 290–298 Article CAS PubMed Google Scholar * Kyle RA,
Gertz MA, Greipp PR _et al_. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine _New Engl J Med_ 1997
336: 1202–1207 Article CAS PubMed Google Scholar * Gertz MA, Kyle RA, Greipp PR . Response rates and survival in primary systemic amyloidosis _Blood_ 1991 77: 257–262 CAS PubMed Google
Scholar * Gertz MA, Lacy MQ, Lust JA _et al_. Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the
treatment of primary systemic amyloidosis _J Clin Oncol_ 1999 17: 262–267 Article CAS PubMed Google Scholar * Gillmore JD, Davies J, Iqbal A _et al_. Allogeneic bone marrow
transplantation for systemic AL amyloidosis _Br J Haematol_ 1998 100: 226–228 Article CAS PubMed Google Scholar * Guillaume B, Straetmans N, Jadoul M _et al_. Allogeneic bone marrow
transplantation for AL amyloidosis _Bone Marrow Transplant_ 1997 20: 907–908 Article CAS PubMed Google Scholar * Comenzo RL, Vosburgh E, Falk RH _et al_. Dose-intensive melphalan with
blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients _Blood_ 1998 91: 3662–3670 CAS PubMed Google Scholar * Comenzo R,
Falk R, Sanchorawala V . Treating AL amyloidosis (AL) with dose intensive melphalan: outcomes in 102 patients _Blood_ 1998 92: 324A (Abstr.) Google Scholar * Moreau P, Leblond V, Bourquelot
P _et al_. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients _Br J Haematol_
1998 101: 766–769 Article CAS PubMed Google Scholar * Yood RA, Skinner M, Rubinow A _et al_. Bleeding manifestations in 100 patients with amyloidosis _JAMA_ 1983 249: 1322–1324 Article
CAS PubMed Google Scholar * Rocken C, Saeger W, Linke RP . Gastrointestinal amyloid deposits in old age. Report on 110 consecutive autopsical patients and 98 retrospective bioptic
specimens _Pathol Res Pract_ 1994 190: 641–649 Article CAS PubMed Google Scholar * Lee JG, Wilson JA, Gottfried MR . Gastrointestinal manifestations of amyloidosis _South Med J_ 1994 87:
243–247 Article CAS PubMed Google Scholar * Carrizosa J, Lin KY, Myerson RM . Gastrointestinal neuropathy in familial amyloidosis. Report of a case with severe diarrhea without
steatorrhea or malabsorption _Am J Gastroenterol_ 1973 59: 541–546 CAS PubMed Google Scholar * Levy DJ, Franklin GO, Rosenthal WS . Gastrointestinal bleeding and amyloidosis _Am J
Gastroenterol_ 1982 77: 422–426 CAS PubMed Google Scholar * Bjornsson S, Johannsson JH, Sigurjonsson F . Localized primary amyloidosis of the stomach presenting with gastric hemorrhage
_Acta Med Scand_ 1987 221: 115–119 Article CAS PubMed Google Scholar * Schroeder FM, Miller FJ Jr, Nelson JA, Rankin RS . Gastrointestinal angiographic findings in systemic amyloidosis
_Am J Roentgenol_ 1978 131: 143–146 Article CAS Google Scholar * Gastineau DA, Gertz MA, Daniels TM _et al_. Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation
abnormality _Blood_ 1991 77: 2637–2640 CAS PubMed Google Scholar * Lovat LB, Pepys MB, Hawkins PN . Amyloid and the gut _Dig Dis_ 1997 15: 155–171 Article CAS PubMed Google Scholar *
Thaler W, Schatzer G, Eder P, Fichtel G . Amyloidosis – an unusual case of recurrent intestinal bleeding and sigmoid perforation: case report with review of the literature _Int J Colorectal
Dis_ 1999 14: 297–299 Article CAS PubMed Google Scholar * Lau CF, Fok KO, Hui PK _et al_. Intestinal obstruction and gastrointestinal bleeding due to systemic amyloidosis in a woman with
occult plasma cell dyscrasia _Eur J Gastroenterol Hepatol_ 1999 11: 681–685 Article CAS PubMed Google Scholar * Gupta OK, Tandon RK . Intestinal malabsorption, obstruction, bleeding and
perforation in primary amyloidosis (a case report) _J Assoc Phys India_ 1976 24: 395–398 CAS Google Scholar * Cauble WG . GI bleeding caused by amyloidosis _J Kans Med Soc_ 1984 85:
292–293 CAS PubMed Google Scholar * Barzola S, Lespi P, Fuentes R . Intestinal bleeding associated with systemic amyloidosis (Spanish) _Acta Gastroenterol Latinoam_ 1998 28: 257–259 CAS
PubMed Google Scholar * O'Grady JF, O'Connell TC . Primary systemic amyloidosis presenting with severe intestinal haemorrhage _Ir J Med Sci_ 1968 7: 445–448 Article CAS PubMed
Google Scholar * Brandt K, Cathcart ES, Cohen AS . A clinical analysis of the course and prognosis of forty-two patients with amyloidosis _Am J Med_ 1968 44: 955–969 Article CAS PubMed
Google Scholar * Gilat T, Spiro HM . Amyloidosis and the gut _Am J Dig Dis_ 1968 13: 619–633 Article CAS PubMed Google Scholar * Gilat T, Revach M, Sohar E . Deposition of amyloid in
the gastrointestinal tract _Gut_ 1969 10: 98–104 Article CAS PubMed PubMed Central Google Scholar * Mallory A, Struthers JE Jr, Kern F Jr . Persistent hypotension and intestinal
infarction in a patient with primary amyloidosis _Gastroenterology_ 1975 68: 1587–1592 CAS PubMed Google Scholar * Kyle RA, Bayrd ED . Amyloidosis: review of 236 cases _Medicine (Balt)_
1975 54: 271–299 Article CAS Google Scholar * Bernhardt B, Valletta M, Brook J, Lejnieks I . Amyloidosis with factor X deficiency _Am J Med Sci_ 1972 264: 411–414 Article CAS PubMed
Google Scholar * Quitt M, Aghai E, David M _et al_. Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome _Scand J Haematol_ 1985
35: 155–157 Article CAS PubMed Google Scholar * Furie B, Voo L, McAdam KP, Furie BC . Mechanism of factor X deficiency in systemic amyloidosis _New Engl J Med_ 1981 304: 827–830 Article
CAS PubMed Google Scholar * Gamba G, Montani N, Anesi E _et al_. Abnormalities in thrombin-antithrombin pathway in AL amyloidosis _Amyloid_ 1999 6: 273–277 Article CAS PubMed Google
Scholar * Drijfhout HH, Knot EA, ten Cate JW . Antithrombin III metabolism in two patients with a nephrotic syndrome caused by minimal chain nephritis and primary amyloidosis _Haemostasis_
1987 17: 286–292 CAS PubMed Google Scholar * Figler TJ, Keshavarzian A, Nand S, Demos TC . Retroperitoneal amyloidosis, factor IX and X deficiency, and gastrointestinal bleeding _Abdom
Imaging_ 1996 21: 266–268 Article CAS PubMed Google Scholar * Kaur S, Cooper G, Fakult S, Lazarus HM . Incidence and outcome of overt gastrointestinal bleeding in patients undergoing
bone marrow transplantation _Dig Dis Sci_ 1996 41: 598–603 Article CAS PubMed Google Scholar * Marmaduke DP, Greenson JK, Cunningham I _et al_. Gastric vascular ectasia in patients
undergoing bone marrow transplantation _Am J Clin Pathol_ 1994 102: 194–198 Article CAS PubMed Google Scholar * Wolford J, McDonald G . Gastrointestinal bleeding after marrow transplant:
a prospective study of risk factors, etiology, and outcome _Gastroenterology_ 1987 92: 1697 (Abstr.) Google Scholar * Shuhart M, McDonald G . Gastrointestinal and hepatic complications In:
Forman SJ, Blume KG, Thomas ED (eds) _Bone Marrow Transplantation_ Blackwell Scientific Publications: Cambridge, MA 1994 pp 454–481 Google Scholar * Nevo S, Swan V, Enger C _et al_. Acute
bleeding after bone marrow transplantation (BMT) – incidence and effect on survival. A quantitative analysis in 1402 patients _Blood_ 1998 91: 1469–1477 CAS PubMed Google Scholar * Price
KJ, Thall PF, Kish SK _et al_. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit _Am J Respir Crit Care Med_ 1998 158: 876–884 Article CAS
PubMed Google Scholar * Mehta J, Nagler A, Slavin S . Marrow transplantation in multiple myeloma (letter) _New Engl J Med_ 1992 326: 1087 CAS PubMed Google Scholar * Gillmore JD,
Hawkins PN, Pepys MB . Amyloidosis: a review of recent diagnostic and therapeutic developments _Br J Haematol_ 1997 99: 245–256 Article CAS PubMed Google Scholar * Comenzo RL,
Sanchorawala V, Fisher C _et al_. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM + G-CSF or G-CSF alone to treat AL (amyloid light chain)
amyloidosis _Br J Haematol_ 1999 104: 553–559 Article CAS PubMed Google Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Division of Hematology and Internal
Medicine, Mayo Clinic, Rochester, MN, USA S Kumar, A Dispenzieri, MQ Lacy, MR Litzow & MA Gertz Authors * S Kumar View author publications You can also search for this author inPubMed
Google Scholar * A Dispenzieri View author publications You can also search for this author inPubMed Google Scholar * MQ Lacy View author publications You can also search for this author
inPubMed Google Scholar * MR Litzow View author publications You can also search for this author inPubMed Google Scholar * MA Gertz View author publications You can also search for this
author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Kumar, S., Dispenzieri, A., Lacy, M. _et al._ High incidence of
gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. _Bone Marrow Transplant_ 28, 381–385 (2001). https://doi.org/10.1038/sj.bmt.1703155
Download citation * Received: 18 April 2001 * Accepted: 11 June 2001 * Published: 18 September 2001 * Issue Date: 01 August 2001 * DOI: https://doi.org/10.1038/sj.bmt.1703155 SHARE THIS
ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * GI bleeding * high-dose chemotherapy * stem cell transplantation * systemic amyloidosis
Trending News
Let Us Rock N Roll - Patna NewsBY: INEXTLIVE | Updated Date: Mon, 25 Jun 2012 12:04:03 (IST) हिप-हॉप से सालसा तक आई नेक्स्ट तथा रॉक एन रोल आर्ट एंड क्र...
'behind her eyes' viewers call out netflix show for 'homophobic' ending_Behind Her Eyes_ is the latest hit thriller on Netflix, with the show currently the most-watched show in the world on t...
Bjp of misusing government machinery: mayawatiLucknow, May 1 (IANS) Bahujan Samaj Party (BSP) supremo Mayawati here on Wednesday accused the Bharatiya Janata Party (B...
Genetic architectures of cerebral ventricles and their overlap with neuropsychiatric traitsABSTRACT The cerebral ventricles are recognized as windows into brain development and disease, yet their genetic archite...
Smoking cessation drugs marketYou have full access to this article via your institution. Download PDF Image courtesy of Squint (www.squintlimited.com)...
Latests News
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosisABSTRACT Peripheral blood stem cell transplants have been associated with better response rates than conventional chemot...
Innovative disease control: synthetic compartments stop pathogens from sharing antibiotic resistance genesEMERGING FIELD OF SYNTHETIC CONDENSATES ISOLATES OR TRAPS TOGETHER BIOMOLECULES TO CONTROL CELLULAR PROCESSES. Biomedica...
Holographic photolysis of caged neurotransmittersABSTRACT Stimulation of light-sensitive chemical probes has become a powerful tool for the study of dynamic signaling pr...
What are ‘fasting’ diets and do they help you lose weight?Trying to lose weight is hard work. You need to plan meals and snacks, and make a big effort to avoid situations that tr...
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesisABSTRACT Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide, develops almost exclusi...